PPARA and melanoma: Despite several in vitro and in vivo studies revealing the beneficiary potential of PPARs ligands in the inhibition of melanoma initiation, progression, and metastasis, clinical studies did not bring such optimistic conclusions in the sole use of PPAR ligands in melanoma therapy.